HIGHLIGHTS
- who: Steeve Boulant and colleagues from the Department of Molecular Medicine, Sapienza University of Rome, Italy have published the research: Editorial: Type III interferons: Emerging roles beyond antiviral barrier defense, in the Journal: (JOURNAL)
- future: Work is needed to expand the understanding of IFN-l and bacterial interactions.
SUMMARY
Type III interferons or IFN-ls, are composed of 4 members: IFN-l1, IFN-l2, IFNl3, and IFN-l4. IFN-ls are master protectors against mucosal viral infections due to the preferential expression of their cognate receptor, IFNLR1, to cells of epithelial . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.